| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Revenue | $1.89B | +14.5% |
| Cost of Revenue | $990.0M | +8.4% |
| Gross Profit | $904.0M | +22.0% |
| R&D Expense | $1.15B | +6.3% |
| SG&A Expense | $80.0M | +14.3% |
| Operating Income | -$440.0M | +86.4% |
| Pre-tax Income | -$377.0M | +88.1% |
| Income Tax | $15.0M | +120.5% |
| Net Income | -$392.0M |
| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.84B | +28.8% |
| Accounts Receivable | $131.0M | -38.2% |
| Inventory | $327.0M | -21.2% |
| Current Assets | $2.48B | +14.0% |
| Total Assets | $12.49B | -0.7% |
| Current Liabilities | $406.0M | +21.9% |
| Total Liabilities | $611.0M | +24.2% |
| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $602.0M | +50.5% |
| Capital Expenditures | $79.0M | -2.5% |
| Investing Cash Flow | -$91.0M | +24.2% |
| Financing Cash Flow | -$106.0M | -60.6% |
| Free Cash Flow | $523.0M | +63.9% |
| +87.3% |
| EPS (Basic) | -$0.48 | +87.4% |
| EPS (Diluted) | -$0.48 | +87.4% |
| Stockholders' Equity |
| $11.88B |
| -1.7% |